Document Detail

Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term.
MedLine Citation:
PMID:  15582072     Owner:  NLM     Status:  MEDLINE    
PURPOSE: To compare the conjunctival epithelial cell expressions of inflammatory cytokines in normal subjects and in glaucoma patients treated over the long term. DESIGN: Case-control study. PARTICIPANTS: A total of 69 glaucoma patients treated over the long term and 15 normal subjects with no ocular abnormality or topical treatment. METHODS: Amongst the 69 glaucoma patients, 27 were treated with preserved beta-blockers, 24 with unpreserved 0.5% timolol, and the other 18 patients with an association of > or =2 preserved drugs. All patients were treated for more than 1 year with the same treatment, with no significant differences between groups for mean ages and durations of treatment at the time of the study. Impression cytology specimens were taken and processed for immunofluorescence techniques. Conjunctival cell expressions of HLA DR, as a standard for inflammatory level, and the interleukins IL-6, IL-8, and IL-10 were obtained and quantified using flow cytometry. MAIN OUTCOME MEASURES: Immune markers and proinflammatory cytokines in impression cytology specimens. RESULTS: We found a significantly increased expression of all immunoinflammatory markers and mediators in the conjunctival epithelium of glaucoma patients compared with normal eyes. Human leukocyte antigen DR was significantly higher in the 2 groups receiving preserved drugs than in the unpreserved timolol group. The 3 interleukins were similarly overexpressed in all glaucoma groups, with no significant between-groups differences except for the expression level of IL-8, which was significantly higher in the multitreatment group than in the preservative-free one. CONCLUSIONS: The present study confirms the increased expression of immunoinflammatory markers by the conjunctival epithelium of glaucoma patients treated over the long term. The development of nontoxic preservatives or preservative-free solutions is therefore of great interest.
Christophe Baudouin; Pascale Hamard; Hong Liang; Catherine Creuzot-Garcher; Larry Bensoussan; Françoise Brignole
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Ophthalmology     Volume:  111     ISSN:  1549-4713     ISO Abbreviation:  Ophthalmology     Publication Date:  2004 Dec 
Date Detail:
Created Date:  2004-12-07     Completed Date:  2004-12-20     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7802443     Medline TA:  Ophthalmology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2186-92     Citation Subset:  IM    
Department of Ophthalmology, Quinze-Vingts National Ophthalmology Hospital, APHP, Paris-Ouest School of Medicine, University of Versailles, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Antihypertensive Agents / therapeutic use*
Biological Markers / metabolism
Case-Control Studies
Chronic Disease
Conjunctiva / metabolism*,  pathology
Epithelial Cells / metabolism*
Flow Cytometry
Fluorescent Antibody Technique, Indirect
Glaucoma, Open-Angle / drug therapy,  metabolism*,  pathology
HLA-DR Antigens / metabolism*
Interleukins / metabolism*
Middle Aged
Preservatives, Pharmaceutical / therapeutic use
Reg. No./Substance:
0/Antihypertensive Agents; 0/Biological Markers; 0/HLA-DR Antigens; 0/Interleukins; 0/Preservatives, Pharmaceutical

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Wavefront-guided LASIK with the Zyoptix 3.1 system for the correction of myopia and compound myopic ...
Next Document:  Detection of the free acid of bimatoprost in aqueous humor samples from human eyes treated with bima...